Evidence map›Paper›PMID 19497850›Full record

ArticleThe Journal of biological chemistry2009

Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin.

Shahid Umar, Shubhashish Sarkar, Yu Wang, Pomila Singh

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Inflammation and Cancer: In Medio Stat Nano.Current medicinal chemistry · 2018
    Review
  7. New Data on Human Macrophages Polarization byFrontiers in immunology · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Epigenetic regulation of humanStem cell investigation · 2016
    Article
  13. Article
  14. Review
  15. Novel roles of gastrin.The Journal of physiology · 2014
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shahid UmarDepartment of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; Internal Medicine, University of Texas Medical Branch, Galveston, Texas 77555.
Shubhashish Sarkarthe Departments of Neuroscience and Cell Biology, Galveston, Texas 77555.
Yu Wangthe Departments of Neuroscience and Cell Biology, Galveston, Texas 77555.
Pomila Singhthe Departments of Neuroscience and Cell Biology, Galveston, Texas 77555.
The University of Texas Medical Branch at Galveston · US

Funding

Role of Annexin-II in growth factor/co-carcinogenic effects of progastrinR01CA097959 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SINGH, POMILA · 2003 to 2015
$3.7M
Growth Factors, Curcumin and Colon CarcinogenesisR01CA114264 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SINGH, POMILA · 2006 to 2010
$1.3M
Beta-Catenin/NF-kB in Hyperplasia/Neoplasia of Colonic Crypts: ChemopreventionR01CA131413 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI UMAR, SHAHID · 2008 to 2011
$1.2M
NCI NIH HHS CA114264NCI NIH HHS R01 CA097959NCI NIH HHS R01 CA114264NCI NIH HHS R01 CA131413NCI NIH HHS R01 CA97959
6 · The paper itself

Abstract

We recently reported a critical role of NFkappaB in mediating hyperproliferative and anti-apoptotic effects of progastrin on proximal colonic crypts of transgenic mice overexpressing progastrin (Fabp-PG mice). We now report activation of beta-catenin in colonic crypts of mice in response to chronic (Fabp-PG mice) and acute (wild type FVB/N mice) progastrin stimulation. Significant increases were measured in relative levels of cellular and nuclear beta-catenin and pbeta-cat45 in proximal colonic crypts of Fabp-PG mice compared with that in wild type littermates. Distal colonic crypts were less responsive. Interestingly, beta-catenin activation was downstream of IKKalpha,beta/NFkappaB, because treatment of Fabp-PG mice with the NFkappaB essential modulator (NEMO) peptide (inhibitor of IKKalpha,beta/NFkappaB activation) significantly blocked increases in cellular/nuclear levels of total beta-catenin/pbeta-cat45/and pbeta-cat552 in proximal colons. Cellular levels of pbeta-cat33,37,41, however, increased in proximal colons in response to NEMO, probably because of a significant increase in pGSK-3betaTyr216, facilitating degradation of beta-catenin. NEMO peptide significantly blocked increases in cyclin D1 expression, thereby, abrogating hyperplasia of proximal crypts. Goblet cell hyperplasia in colonic crypts of Fabp-PG mice was abrogated by NEMO treatment, suggesting a cross-talk between the NFkappaB/beta-catenin and Notch pathways. Cellular proliferation and crypt lengths increased significantly in proximal but not distal crypts of FVB/N mice injected with 1 nM progastrin associated with a significant increase in cellular/nuclear levels of total beta-catenin and cyclin D1. Thus, intracellular signals, activated in response to acute and chronic stimulation with progastrin, were similar and specific to proximal colons. Our studies suggest a novel possibility that activation of beta-catenin, downstream to the IKKalpha,beta/NFkappaB pathway, may be integral to the hyperproliferative effects of progastrin on proximal colonic crypts.

Indexed as

Gene Expression RegulationAnimalsbeta CateninCell ProliferationColonCyclin D1GastrinsGoblet CellsHomozygoteHyperplasiaMiceMice, TransgenicModels, BiologicalNF-kappa BProtein PrecursorsSignal Transductionbeta Cateninbig gastrinCyclin D1GastrinsNF-kappa BProtein Precursors

Identifiers

PMID19497850
PMCPMC2755951
OpenAlexW2047972120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.